US Patent 7951386 None
Patent 7951386 was granted and assigned to Cornell University Press on May, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+595 characters)
Article
Patent abstract
This invention provides the sequence of 5,299 nucleotides from the E. canis genome. There are four proteins, ProA, ProB, MmpA, and a cytochrome oxidase homolog, as well as a partial lipoprotein signal peptidase homolog at the carboxy terminus, coded for in this cloned fragment. The antigenic properties of these proteins allow them to be used to create a vaccine. An embodiment of this invention includes the creation of a DNA vaccine, a recombinant vaccine, and a T cell epitope vaccine. Another embodiment of this invention includes the use of serological diagnosis techniques.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Yung-Fu Chang0
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07951386 None US Patent 7951386 None
Infobox
Patent Number
079513860
Patent Number
79513860
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079513860
Date of Patent
May 31, 2011
0Patent Application Number
120171440
Date Filed
January 21, 2008
0Patent Primary Examiner
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07951386 None
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07951386
Date of patent
May 31, 2011
Patent application number
12017144
Date Filed
January 21, 2008
Patent primary examiner
Find more entities like US Patent 7951386 None
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.